Dehaier Announces the Results of 2014 Shareholder Annual Meeting
July 30 2014 - 9:00AM
Dehaier Medical Systems Ltd. (Nasdaq:DHRM)
("Dehaier" or the "Company"), an emerging leader in the
development, assembly, marketing and sale of medical devices and
sleep respiratory products in China, today announced the results of
its 2014 annual general meeting of shareholders.
The shareholders of Dehaier have approved all the matters
submitted to them at the Company's 2014 annual general meeting held
on 9:00 p.m., Eastern Standard Time, on Monday, July 28, 2014. A
total of 3,694,277 shares were represented in person or by proxy at
the Company's 2014 annual general meeting, representing a quorum of
approximately 65.77% of the Company's outstanding shares. During
the meeting, the following resolutions were duly passed:
(i) Election of two Class I members of the Board of Directors,
to serve a term expiring at the Annual Meeting of Shareholders in
2017 or until their successors are duly elected and qualified;
(ii) Ratification of the appointment of Friedman LLP as the
Company's independent registered public accounting firm for the
fiscal year ending December 31, 2014;
(iii) Approval of the Company's 2014 Share Incentive Plan;
and
(iv) Transaction of any other business properly coming
before the meeting.
Mr. Ping Chen, Dehaier's CEO and Chairman, stated, "On behalf of
management, I would like to thank shareholders for their support
and confidence in Dehaier. We will continue to focus on enhancing
shareholder value as deploying our strategic planning of sleep
respiratory business to further diversifying our growth strategies
in the future."
Dehaier's 2014 Shareholder Annual Meeting will be available
online for a limited time at:
http://www.media-server.com/m/p/ypjotr75.
About Dehaier Medical Systems Ltd.
Dehaier is an emerging leader in the development, assembly,
marketing and sale of medical products, including medical devices
and sleep respiratory products. The company develops and assembles
its self-branded medical devices and sleep respiratory products
from third-party components. The company also distributes products
designed and manufactured by other companies, including medical
devices from IMD (Italy), HEYER (Germany) and Timesco (UK).
Dehaier's technology is based on six patents and eleven software
copyrights. More information can be found at
http://www.dehaier.com.cn
Forward-looking Statements
This news release contains forward-looking statements as defined
by the Private Securities Litigation Reform Act of 1995.
Forward-looking statements include statements concerning plans,
objectives, goals, strategies, future events or performance, and
underlying assumptions and other statements that are other than
statements of historical facts. These statements are subject to
uncertainties and risks including, but not limited to, product and
service demand and acceptance, fulfillment of bids and contracts,
changes in technology, economic conditions, the impact of
competition and pricing, government regulation, and other risks
contained in reports filed by the company with the Securities and
Exchange Commission. All such forward-looking statements, whether
written or oral, and whether made by or on behalf of the company,
are expressly qualified by the cautionary statements and any other
cautionary statements which may accompany the forward-looking
statements. In addition, the company disclaims any obligation to
update any forward-looking statements to reflect events or
circumstances after the date hereof.
CONTACT: Dehaier Medical Systems Limited
+86 10-5166-0080
Janice Wang
wangxq@dehaier.com.cn
Lianluo Smart (NASDAQ:LLIT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Lianluo Smart (NASDAQ:LLIT)
Historical Stock Chart
From Apr 2023 to Apr 2024